- Home
- ABBV vs RY Comparison
ABBV vs RY Comparison
Compare ABBV & RY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABBV | RY |
|---|---|---|
| Founded | 2012 | 1864 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 292.3B |
| IPO Year | 2012 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ABBV | RY |
|---|---|---|
| Price | $265.89 | $207.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $253.71 | $162.00 |
| AVG Volume (30 Days) | ★ 3.7M | 1.1M |
| Earning Date | 04-29-2026 | 05-28-2026 |
| Dividend Yield | ★ 3.39% | 2.64% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.42 | N/A |
| Revenue | ★ $61,160,000,000.00 | N/A |
| Revenue This Year | $11.87 | $17.42 |
| Revenue Next Year | $8.12 | $4.52 |
| P/E Ratio | $109.82 | ★ $17.01 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $190.75 | $143.13 |
| 52 Week High | $267.47 | $218.57 |
Technical Indicators
Market Signals| Indicator | ABBV | RY |
|---|---|---|
| Relative Strength Index (RSI) | 64.27 | 40.75 |
| Support Level | $218.78 | $166.12 |
| Resistance Level | $267.47 | $218.34 |
| Average True Range (ATR) | 5.08 | 3.30 |
| MACD | 1.38 | -1.27 |
| Stochastic Oscillator | 94.43 | 23.04 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About RY Royal Bank Of Canada
Royal Bank of Canada is one of the two largest banks in Canada, with around CAD 2.4 trillion in assets at the end of April 2026. It is a diversified financial services company, offering personal and commercial banking, wealth management, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada and has dominant market shares. RBC also has wealth and capital market businesses in the US, UK, and other countries. RBC is a top 15 investment bank globally.